Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2005
09/08/2005US20050196379 Combination therapies with L-FMAU for the treatment of hepatitis B virus infection
09/08/2005DE102004017793A1 Use of trioxacarcins for treatment and prevention of infectious diseases, also new trioxacarcins for treatment of e.g. tumors, inflammatory and autoimmune diseases
09/07/2005EP1571214A2 Immunogenic detoxified mutant toxin
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor
09/07/2005EP1570854A1 Drug containing angiotensin convertase
09/07/2005EP1570840A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
09/07/2005EP1570089A1 Molecules inhibiting hepatitis c virus protein synthesis and method for screening same
09/07/2005EP1569935A1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors
09/07/2005EP1569933A1 Pyrrolidine and azetidine compounds as ccr5 antagonists
09/07/2005EP1569931A1 Heterocyclic compounds as ccr5 antagonists
09/07/2005EP1569907A1 Nicotinamide-based kinase inhibitors
09/07/2005EP1569688A1 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies
09/07/2005EP1569659A2 Dioxolane thymine and combinations for use against 3tc/ azt resistant strains of hiv
09/07/2005EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
09/07/2005EP1569656A2 Phosphoantigens for regulating an immune response
09/07/2005EP1569652A2 N sp 4 /sp-acylcytosine nucleosides for treatment of viral iinfections
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1569646A2 Piperidine derivatives as ccr5 antagonists
09/07/2005EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
09/07/2005EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
09/07/2005EP1447094A9 Remedies for pruritus
09/07/2005EP1443952A4 A method of reducing mortality and morbidity associated with critical illnesses
09/07/2005EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/07/2005EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors
09/07/2005EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
09/07/2005EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
09/07/2005EP1270575B1 Novel crystal form of pyrrolidylthiocarbapenem derivative
09/07/2005EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors
09/07/2005EP1214314B1 Aminopiperidine derivatives as antibacterials
09/07/2005EP1104291B1 Pellets having a core coated with an antifungal and a polymer
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins
09/07/2005CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
09/07/2005CN1665921A Adenovirus vectors for immunotherapy
09/07/2005CN1665920A Liver engrafting cells, assays, and uses thereof
09/07/2005CN1665842A Human IgM antibody inducing apoptosis in HIV-infected cells and remedy for HIV-infection
09/07/2005CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
09/07/2005CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use
09/07/2005CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
09/07/2005CN1665810A Inhibitors of JAK and CDK2 protein kinases
09/07/2005CN1665806A Medicine compound
09/07/2005CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism
09/07/2005CN1665801A Anti tubercular drug: compositions and methods
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665566A Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c
09/07/2005CN1665535A Perylenequinones for use with immunotherapy agents
09/07/2005CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics
09/07/2005CN1665531A Cancer vaccines and methods of using the same
09/07/2005CN1665529A Method to enhance an immune response of nucleic acid vaccination
09/07/2005CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665515A Methods for treating psychosis associated with interferon-alpha therapy
09/07/2005CN1665509A Synergistic interaction of abacavir and alovudine
09/07/2005CN1665504A Novel crystalline forms of gatifloxacin
09/07/2005CN1665484A Warming and nonirritating lubricant compositions and method of comparing irritation
09/07/2005CN1665483A Solid dispersion comprising two different polymer matrixes
09/07/2005CN1663963A Hybrid interferon compositions and methods of use
09/07/2005CN1663615A Fructose injection of antibiotic medicine
09/07/2005CN1663612A Preparation method of natural antibody silkworm protein capable of preventing AIDS
09/07/2005CN1663611A Application of chitosan for preparing helicobacter pylorus vaccine adjuvant
09/07/2005CN1663610A Lysozyme preparation
09/07/2005CN1663593A Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation and medical usage
09/07/2005CN1663589A Cordate houttuynia mixture for preventing and treating livestock bird infectious disease
09/07/2005CN1663585A Pharmaceutical composition for resisting herpes simplex virus and its preparing process
09/07/2005CN1663570A Pharmaceutical composition with anti-infection, fever-relieving, pain-stopping functions
09/07/2005CN1663568A Compound formulation for effectively preventing and treating virus infection
09/07/2005CN1663566A Itraconazole hydrochloride composition and freeze-dried powder injection thereof
09/07/2005CN1663562A Application of flavone monomer in antivirus drug preparing process
09/07/2005CN1217951C Processes for preparing clarithromycin polymorphs and novel polymorph IV
09/07/2005CN1217944C Crystal modification D of 8-cyano-1-cyclopropyl-7-(1S, 6S-2, 8-diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinoline carboxylic acid
09/07/2005CN1217939C Compound of phycocyania of blue-green algae, its preparing method and usage
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217929C Amycomycin, production thereof and its use as pharmaceutical
09/07/2005CN1217926C Novel vitamin D analogues
09/07/2005CN1217698C Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents
09/07/2005CN1217697C Peptide antagonists of zonulin and methods for use of same
09/07/2005CN1217694C A reducing fever anti-cold medicine combination and the preparation process thereof
09/07/2005CN1217690C Chinese medicine for treating bacillary dysentery and producing method thereof
09/07/2005CN1217687C Chinese herbal medicine for treating smelly feet and its preparing method
09/07/2005CN1217674C Snuff pill for treating TB and ulcer
09/07/2005CN1217672C Medicine for preventing and treating hepatitis prepared from mudlump and its preparation
09/07/2005CN1217668C Sustained release formulations of erythromycin derivatives
09/07/2005CN1217655C Fibrauretine slow releasing preparation
09/07/2005CN1217584C Effervescent green tea extract formulation
09/06/2005US6939971 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent
09/06/2005US6939959 Efficient protein expression system
09/06/2005US6939947 administering glycoproteins as antibiotics for prophylaxis of bacterial infections; vancomycin derivatives; peptide antibiotics
09/06/2005US6939946 Ring modified cyclic peptide analogs
09/06/2005US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
09/06/2005US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
09/06/2005US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds
09/06/2005US6939840 Disinfectant
09/06/2005US6939568 Hydrated dressing containing metal microbiocide
09/06/2005US6939549 To reduce the severity or prevent infection by ehrlichial parasites of the species Anaplasma marginale
09/06/2005US6939547 Specific binding agents for KSHV vIL-6 that neutralize a biological activity
09/06/2005US6939543 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/06/2005US6939541 Polypeptide for use in the treatment of viral diseases and cancer
09/06/2005CA2193329C Water soluble rapamycin esters
09/06/2005CA2119516C Ointment for wound treatment
1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 1798